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Abstract: The objective of this review was to examine the evidentiary basis for binge 
eating disorder (BED) with reference to the Diagnostic and Statistical Manual of Mental 
Disorders – Fifth Edition (DSM-5) diagnostic criteria for BED. A PubMed search restricted 
to titles and abstracts of English-language reviews, meta-analyses, clinical trials, random-
ized controlled trials, journal articles, and letters using human participants was conducted on 
August 7, 2015, using keywords that included “binge eating disorder,” DSM-5, DSM-IV, guilt, 
shame, embarrassment, quantity, psychological, behavior, and “shape and weight concerns.” 
Of the 257 retrieved publications, 60 publications were considered relevant to discussions 
related to DSM-5 diagnostic criteria and were included in the current review, and 20 additional 
references were also included on the basis of the authors’ knowledge and/or on a review of 
the reference lists from relevant articles obtained through the literature search. Evidence sup-
ports the duration/frequency criterion for BED and the primary importance of loss of control 
and marked distress in identifying individuals with BED. Although overvaluation of shape/
weight is not a diagnostic criterion, its relationship to the severity of BED psychopathology 
may identify a unique subset of individuals with BED. Additionally, individuals with BED 
often exhibit a clinical profile consisting of psychiatric (eg, mood, obsessive–compulsive, and 
impulsive disorders) and medical (eg, gastrointestinal symptoms, metabolic syndrome, and type 
2 diabetes) comorbidities and behavioral profiles (eg, overconsumption of calories outside of 
a binge eating episode and emotional eating). Future revisions of the BED diagnostic criteria 
should consider the inclusion of BED subtypes, perhaps based on the overvaluation of shape/
weight, and an evidence-based reassessment of severity criteria. 
Keywords: binge eating disorder, diagnosis, obesity, psychotherapy, pharmacotherapy, 
psychopathology
Introduction
As of May 2013, the Diagnostic and Statistical Manual of Mental Disorders – Fifth 
Edition (DSM-5)1 recognized binge eating disorder (BED) as a distinct eating disor-
der. To be diagnosed with BED according to DSM-5 criteria, there must be recurrent 
binge eating episodes (occurring on average at least once a week for 3 months) 
characterized by the consumption of larger amounts of food in a discrete period than 
is typical for most people under similar circumstances and a sense of loss of control 
over eating during these episodes, and there must also be marked distress associated 
with the binge eating behavior.1 Unlike bulimia nervosa (BN) and anorexia nervosa of 
the binge eating/purging type (AN-BE/P), there are no recurrent inappropriate com-
pensatory behaviors, such as excessive exercise or purging, with BED.1 The DSM-5 
also delineates severity criteria for BED, with the minimum level of severity based on 
the number of weekly binge eating episodes (mild, 1–3; moderate, 4–7; severe, 8–13; 
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and extreme, 14); severity level can be increased to reflect 
other symptoms and functional disability.1 
BED was recognized as a clinical condition as early as 
1959.2 However, it first appeared in the DSM-IV 3 as a provi-
sional diagnosis that required further study. Thus, individuals 
meeting the criteria for BED were diagnosed with an eating 
disorder not otherwise specified.3 Subsequent research has 
established BED as a distinct eating disorder, which led to 
its inclusion in the DSM-5.1
Given the recognition of BED in the DSM-5 as a distinct 
eating disorder and the fact that the DSM-5 criteria do not 
differ substantially from the provisional criteria originally 
proposed in the 1990s,4,5 it is worth reviewing the literature 
supporting this diagnosis to better understand the strengths 
and limitations of the current diagnostic criteria. This 
is particularly important because the estimated lifetime 
prevalence of BED in the US based on DSM-IV criteria 
(1.9%–2.8%) exceeds that of both BN (~1.0%) and AN 
(~0.6%).6,7 An improved understanding of the basis for the 
BED diagnostic criteria will be useful information for future 
DSM revisions and potentially benefit treatment selection 
and/or predict treatment response. 
This qualitative review focuses on describing the charac-
teristics of BED with reference to DSM-5 diagnostic criteria 
and highlights the aspects of the DSM-5 diagnostic criteria 
requiring further consideration, including the definition of 
what constitutes a “large amount of food” with reference 
to binge eating, and the lack of inclusion of overvaluation 
of shape and weight as a diagnostic criterion. Thus, this 
review summarizes the evidentiary basis for the DSM-5 BED 
diagnostic criteria; the factors that differentiate BED from 
other eating disorders and obesity; and the comorbidities, 
psychopathologies, functional disabilities, and impaired 
quality of life (QoL) associated with BED. Based on this 
evidence, a discussion on the limitations of the current 
diagnostic criteria and recommendations for future research 
requirements are provided. 
Methods
Literature review
A PubMed search restricted to titles and abstracts of English-
language systematic reviews, meta-analyses, clinical trials, 
randomized controlled trials, journal articles, and letters 
that used human participants was conducted on August 7, 
2015. Search terms used were (“binge eating disorder” OR 
“binge eating”) AND (DSM-5 OR DSM-IV) AND (“loss of 
control” OR guilt OR shame OR embarrassment OR quantity 
OR treat OR treatment OR psychological OR behavior OR 
“shape and weight concerns” OR “shape/weight concerns” 
OR “body image” OR “shape and weight overvaluation” 
OR “shape/weight overvaluation” OR severity OR speci-
fier OR subtyping OR “binge eating frequency” OR comor-
bid OR comorbidities). Although BED can be identified in 
children and adolescents,8,9 only a few meet all symptom 
criteria for BED. Therefore, the current review focuses only 
on the adult literature. It should also be noted that shape and 
weight concerns are not currently included in the diagnostic 
criteria for BED. However, it has been suggested that they 
should be included as a diagnostic specifier or can be used 
for dimensional rating of severity in BED.10 As such, this 
term was included in the literature search so that the evidence 
base for this topic could be reviewed. Additional references 
were included based on the authors’ knowledge of relevant 
articles and on a review of the reference lists from relevant 
articles obtained through the literature search.
Results
Summary of search results
A total of 257 publications were retrieved through the 
PubMed search. Of these, 197 were eliminated as being 
irrelevant to the objectives of this study based on a review 
of the published abstracts, and the remaining 60 publications 
were considered relevant to discussions related to DSM-5 
diagnostic criteria and were included in the current review. 
An additional 20 references were also included based on 
the authors’ knowledge of relevant publications and/or on a 
review of the reference lists from relevant articles obtained 
through the literature search.
Evidence base for DSM-5 BED 
diagnostic criteria
There is variability in the amount of evidence available for the 
individual diagnostic criteria for BED. However, in a study 
that examined the heritability of BED, factor loadings for each 
of the diagnostic criteria for BED were found to be highly 
associated with the propensity toward BED. This finding indi-
cates that each of the BED diagnostic criterion is related to a 
unidimensional construct (ie, a single psychiatric diagnosis).11 
The following sections describe the supportive evidence for 
specific BED diagnostic criteria, highlight the limitations of 
some of these criteria, and discuss the clinical phenotypes 
that are not included in the DSM-5 BED criteria.
Amount of food consumed
Although the BED diagnostic criteria refer to objective 
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a discrete period than what a typical person would consume 
under similar circumstances and eating a large amount of 
food when not physically hungry),1 the role of subjective 
binge eating episodes (eg, eating what is “perceived” by 
that person to be a large amount of food even if it is not an 
amount that is typically considered large)12–14 is not addressed 
in the DSM-5 BED diagnostic criteria. Individuals who report 
only having subjective binge eating episodes do not meet 
DSM-5 diagnostic criteria for BED. Some justification for 
excluding subjective binge eating episodes from the BED 
diagnostic criteria can be derived from the fact that no pub-
lished comparative data on subjective binge eating episodes 
in individuals with versus without BED are available. 
In contrast, the frequency of objective binge eating episodes 
has been shown to be higher in obese individuals with BED 
than in obese individuals without BED.15,16 Furthermore, the 
limited available data on subjective binge eating episodes in 
individuals with BED or in those meeting partial criteria for 
BED indicate that there are few meaningful differences in 
binge eating severity or psychopathology when individuals 
exhibiting subjective versus objective binge eating episodes 
are compared.12,14 To more clearly delineate the relative 
importance of subjective versus objective binge eating 
episodes in BED, systematic assessment of the proportion of 
individuals with DSM-5-defined BED who report subjective 
binge eating episodes and the relative proportions of subjec-
tive versus objective binge eating episodes reported by these 
individuals needs to be carried out. 
In further regard to the amount of food consumed in 
BED, it is also difficult to definitively state what constitutes 
“an amount of food that is definitely larger than what most 
people would eat during a similar time period under similar 
circumstances” because this definition is based on clinical 
judgment, which varies across health care professionals. The 
fact that obese individuals with BED often overconsume 
food relative to obese individuals without BED during 
the periods of normal consumption also complicates this 
issue.17–19 In conclusion, there is a degree of uncertainty about 
what constitutes a “large amount of food” with reference to 
binge eating and, perhaps due to the limited available data 
on individuals with BED, whether subjective binge eating 
should be considered in the BED diagnostic criteria.
Loss of control
Among the diagnostic criteria for BED, a sense of loss of 
control over eating has been shown to be foundational to 
the BED diagnosis.20–26 In a study on obese females being 
assessed for bariatric surgery, the frequency of reporting loss 
of control over eating was higher in participants who self-
reported binge eating (75%) than in those who self-reported 
only overeating (22%).26 In another study that examined 
BED diagnostic criteria using the Questionnaire of Eating 
and Weight Patterns, loss of control over eating was reported 
in 84% of the self-referred individuals who reported binge 
eating or compulsive overeating to be problematic compared 
with 35% of controls who did not.25 The odds of experienc-
ing loss of control over eating were 3.6 times greater in 
individuals with BED than in individuals without BED after 
controlling for affective state and caloric intake, which sug-
gests that loss of control is an inherent component of BED.20 
In support of this conclusion, when females with BED were 
asked to define binge eating, 82% included loss of control.21 
In this same study, responses of the type “feeling totally out 
of control” and “a binge is not being able to stop eating or 
stop before it’s all gone” were typical across participants.21 
However, at least one study that compared treatment-seeking 
obese females with BED to obese females without BED (but 
did not report a loss of control regarding their eating) did not 
report consistent differences in eating symptoms or general 
psychopathology between these groups.27 The authors sug-
gested that the lack of differentiations in this study could 
partly be due to the fact that all participants in the study were 
treatment-seeking and may have been exhibiting higher-level 
eating disorders and psychopathology than non-treatment-
seeking individuals who are obese. 
Binge eating episode characteristics
There is limited evidence in the published literature to sup-
port the individual characteristics of a binge eating episode 
described in the DSM-5. Of the five indicators of impaired 
control listed in the DSM-5 (ie, determinants of loss of control 
during a binge eating episode), eating large amounts of food 
when not hungry and eating alone because of embarrassment 
were found to be the best predictors of a BED diagnosis.22 
Marked distress
The published literature indicates that BED is associated with 
general psychiatric distress15,28–30 and, more specifically, with 
marked distress in regard to binge eating.2,11,23,29,31–34 As early 
as 1959, case reports of Stunkard indicated that marked 
distress was reported in people who binge eat.2 High levels 
of distress related to binge eating are reported in individuals 
with BED who are normal weight and in individuals with 
BED who are obese, suggesting that the distress is not simply 
a consequence of comorbid obesity.33 The integral nature 
of binge eating–related distress in individuals with BED is 
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supported by genetic studies, which indicate that marked 
distress is a heritable component of BED.11 
Individuals with BED demonstrating marked distress 
related to binge eating exhibit increased levels of eating 
disorder pathology and depressive symptoms compared with 
individuals meeting all BED criteria except marked distress 
and with individuals who are obese but do not exhibit binge 
eating or purging behavior.31 Furthermore, levels of distress 
associated with binge eating in individuals with BED have 
been reported to differ as a function of the presence of 
overvaluation of shape and weight, which is associated with 
increased distress,32 and race/ethnicity. Although distress is 
reported across all examined races/ethnicities, higher levels 
of distress associated with binge eating are more likely to 
be reported in individuals who are Latino or Caucasian 
than in individuals who are Asian or African-American.34 
Therefore, although the level of distress may vary across 
subpopulation, the overall literature provides support for 
the legitimacy of the DSM-5 marked distress criterion for 
BED.2,11,23,29,31–34 
Binge eating frequency and duration
Although there was controversy regarding the binge eat-
ing frequency criterion in the DSM-IV – text revision 
(DSM-IV-TR; ie, at least twice a week for 6 months35), which 
was chosen to set a high threshold for diagnosing BED in the 
absence of empirical support for a less stringent criterion,36 
the currently available data support the less stringent criterion 
(ie, at least once a week for 3 months1) of the DSM-5.29,37–40 
For instance, females with subthreshold BED (defined by a 
binge eating frequency of at least once a month for 6 months) 
exhibited eating disorder patterns and psychiatric symptoms, 
with the exception of shape concern, similar to those of 
females with full-syndrome BED (as defined by DSM-IV-TR 
criteria).29 Furthermore, individuals with subthreshold BED 
(binge eating episodes less than twice a week but at least once 
per 28 days or eating 800 kcal per binge at least twice per 
week) did not differ in eating psychopathology, as measured 
by the dietary restraint, disinhibition, and hunger dimensions 
of the Three-Factor Eating Questionnaire, from those meeting 
full DSM-IV-TR BED criteria.38 
It has been suggested that the revised frequency/
duration criterion for BED in the DSM-5 will increase the 
ability to detect binge eating pathology without markedly 
changing lifetime prevalence,40 which would be indicative 
of increased diagnostic sensitivity (ie, the percentage of 
individuals with BED correctly identified as having this 
condition would increase). A study estimated that the 
DSM-5 BED criteria would produce a relative increase 
in the lifetime prevalence of ~3%, with the resulting total 
lifetime prevalence of BED in the United States increas-
ing to 3.6% in females and 2.1% in males.39 Another study 
estimated that lifetime prevalence would increase by 0.18% 
when the frequency/duration criterion shifted from 8 times 
per month for 6 months (the DSM-IV-TR criterion) to 4 
times per month for 3 months (as this study was conducted 
before the release of the DSM-5 BED criteria, it utilized the 
approximate DSM-5 frequency criterion that later became 
the actual criteria).40 Based on the available evidence, the 
less stringent binge eating frequency/duration criterion for 
BED used in the DSM-5 is likely to increase the sensitivity 
of BED diagnosis (ie, ensure that individuals with BED 
are properly diagnosed) without markedly changing its 
specificity (ie, ensure that individuals without BED are not 
diagnosed) relative to the DSM-IV-TR provisional criteria. 
Overall, the available evidence supports the less stringent 
frequency/duration criteria of the DSM-5 compared with the 
provisional criteria of the DSM-IV-TR,29,37–40 even though 
the exact criteria of the DSM-5 have not yet been specifi-
cally validated. 
Differentiating BeD from BN or AN
The DSM-5 diagnostic criteria for BED are intended to iden-
tify individuals who have significant eating pathologies that 
are distinct from those observed in other eating disorders.24 
Diagnostically, BED is distinguished from BN and from 
AN-BE/P by the lack of recurrent compensatory behaviors 
in BED, which are necessary for the diagnosis of BN and 
may be present in AN-BE/P but are not required.1 In addition, 
DSM-5 diagnostic criteria for BED do not include shape and 
weight concerns, which are included in the criteria for both 
AN and BN.1 However, it should be reiterated that a sub-
stantial proportion of individuals with BED report shape and 
weight concerns.10,30,32,41 Perhaps because of these diagnostic 
distinctions, lifetime diagnoses of AN or BN in individuals 
who also meet BED criteria have generally been reported to 
be low (1.5% and 5.9%, respectively) in adults.42 However, 
it should also be noted that diagnostic crossover was reported 
to be higher (BN to BED [23%] and BED to BN [20%]) in a 
community sample of adolescent females,43 suggesting that 
transitions between BN and BED may be more common 
prior to adulthood.
BED differs from AN and BN in terms of prevalence, age 
of onset, and eating behaviors and pathologies.6,7,10,16,31,44–46 
The relative lifetime prevalence of BED in both males and 
females (2.0% in males and 3.5% in females) is higher than 
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that observed in BN (0.5% vs 1.5%) or AN (0.3% vs 0.9%).6 
BED also differs from BN in that it has a later age of onset 
(mean age, 23.3 vs 20.6 years; interquartile range for age 
of onset, 15.5−27.2 years for BED and 14.5−22.9 years 
for BN) and may have a lower persistence (median years 
in episode, 4.3 vs 6.5),7 although others propose that the 
course is comparable.1 In individuals with BED, scores on 
measures of dietary and cognitive restraint are lower than 
that in individuals with BN.10,16,31,44 Individuals with BED 
also exhibit a significantly lower frequency of binge eating 
episodes than do individuals with BN.10,16 However, unlike 
individuals with BN, individuals with BED overconsume 
food during both binge eating episodes and non-binge eating 
episodes.45,46 Overall,6,7,10,16,31,44–46 there is clear evidence that 
BED is distinct from AN and BN. 
Binge eating disorder severity criteria
The DSM-5 provides severity criteria for BED, with the mini-
mum level of severity based on the number of weekly binge 
eating episodes (mild, 1–3; moderate, 4–7; severe, 8–13; 
and extreme, 14), and the severity level can be increased 
to reflect other symptoms and functional disability.1 As of 
the release of the DSM-5 in 2013, there was no empirical 
evidence to support the recommended BED severity cri-
teria of the DSM-5. In two studies published in 2015, the 
BED severity categories of the DSM-5 were evaluated in 
clinical and community populations of adults diagnosed with 
BED.47,48 The percentages of participants in these studies 
(clinical population vs community population) categorized 
as having BED of mild, moderate, severe, and extreme 
severity based on DSM-5 criteria were 39.7% versus 78.1%, 
47.4% versus 19.8%, 10.0% versus 1.8%, and 3% versus 
0.3%, respectively,47,48 indicating that the clinical population 
exhibited more severe BED symptoms as would be expected. 
When the BED severity groups in the clinical population were 
compared across clinical characteristics (Eating Disorder 
Examination [EDE] Questionnaire global and subscale scores 
and Beck Depression Inventory scores), eating pathology 
significantly increased as a function of BED severity on 
three EDE subscales (ie, eating concern, shape concern, and 
weight concern) and on Beck Depression Inventory score.48 
In the community population, increased BED severity was 
associated with increased EDE global and subscale scores.47 
Based on these data, the categorization of BED severity as 
a function of weekly binge eating episodes appears valid. 
However, data providing support for the modification of BED 
severity based on other symptoms or functional disability 
are not available.
Evidence base for factors not 
included as diagnostic criteria 
Obesity
Although obesity is associated with BED, it is not included 
as a diagnostic criterion for BED and the DSM-5 indicates 
that BED is distinct from obesity.1 BED is reported across 
body mass index (BMI) categories but is most common in 
obese individuals (36.2%–42.4%).6,7 A substantial minority 
of individuals seeking weight loss treatment also have a BED 
diagnosis (13%−27%).28,49–51 Among obese individuals, those 
meeting the DSM-5 BED diagnostic criteria are a meaning-
ful and distinct subgroup. Obese individuals with BED have 
poorer psychological functioning (eg, higher depression, 
lower self-esteem, and more emotional eating and shape and 
weight concerns) than obese individuals without BED.15,16,50,52 
In addition, compared with obese individuals without BED, 
obese individuals with BED exhibit distinct eating behaviors 
beyond binge eating. For instance, obese individuals with 
BED consume more calories than obese individuals without 
BED when asked to binge eat in a laboratory setting17–19,53 and 
when asked to eat a normal (ie, nonbinge) meal in a laboratory 
setting.18,19 These findings raise the unanswered question of 
why obese individuals with BED do not have substantially 
higher BMI than obese individuals without BED because 
individuals with BED consume more calories overall and 
have similarly low levels of physical activity.54 
The concept that BED is a phenotype that is distinct from 
obesity is further validated by genetic studies.11,55,56 These 
studies indicate that BED is heritable,11,55,56 that BED clusters 
in families independent of the presence of obesity, and that 
individuals with a family history of BED are at greater risk 
of obesity in adulthood than those with a family history of 
obesity but not with BED.56 Overall, the literature emphasizes 
that there are distinct differences between obese individuals 
with and without BED.15–19,50,52,53
Overvaluation of shape and weight
There has been controversy regarding the role of overvalu-
ation of shape/weight in BED and its lack of inclusion as a 
diagnostic criterion for BED,24,57 in part due to discrepan-
cies in the published literature. Overvaluation of shape/
weight was clinically recognized in individuals with BED 
in the 1990s.58 The literature suggests that overvaluation 
does not simply reflect obesity-related concerns or distress. 
Rather, independent of BMI, it is reliably associated with 
the severity of eating pathology, psychological distress, and 
negative prognostic significance10,15,30,32,41,59 and with worse 
treatment outcomes60–62 in individuals with BED. However, 
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a substantial proportion (~40%) of individuals with BED 
do not exhibit overvaluation of shape and weight,10,32,41 in 
marked contrast to BN where most individuals (95%) exhibit 
overvaluation.10
Despite this discrepancy, individuals with BED who 
exhibit clinically relevant overvaluation of shape/weight 
(defined as scores of 4 on either overvaluation item of 
the EDE) tend to have more severe eating disorder pathol-
ogy, as evidenced by higher scores on the eating concerns 
and dietary restraint subscales of the EDE than those who 
exhibit subclinical overvaluation of shape/weight (defined 
as scores of 4 on both overvaluation items of the EDE).10 
Consistent with a preoccupation with shape/weight, body 
checking behavior (eg, frequent weighing or measuring of fat 
deposits) in obese females with BED is positively correlated 
with overvaluation of weight and depressive symptoms and is 
negatively correlated with self-esteem (although similar cor-
relations were not found in males with BED).63 Overvaluation 
of shape/weight has also been found to be associated with 
psychiatric and social function impairments (eg, depression, 
anxiety, decreased self-esteem, and functional impairments) 
in individuals with BED.15,30,32,59 Individuals with BED who 
do not demonstrate shape/weight overvaluation have been 
reported not to differ substantively from obese individuals 
without BED in terms of eating disorder pathology and 
functional impairment.59
In sum, there is evidence demonstrating that overvalua-
tion of shape/weight is strongly related to eating pathology 
severity in individuals with BED and that it has negative 
prognostic significance in individuals with BED.10,15,30,32,41,57,59 
This suggests that overvaluation of shape/weight should 
be considered as a diagnostic specifier, which designates a 
subtype of BED, or a modifier that could increase the index 
of BED severity. If it were a required diagnostic criterion, it 
would result in the exclusion of a substantial number of indi-
viduals who otherwise do exhibit significant pathology and 
distress10 because a substantial proportion of individuals with 
BED do not exhibit overvaluation of shape/weight.10,32,41 
Comorbidities, psychopathologies, 
functional disabilities, and impaired QoL
As described earlier in this review, the DSM-5 diagnostic 
criteria for severity based on binge eating frequency can be 
adjusted on the basis of the presence of other symptoms and 
by the degree of functional disability.1 Although there is no 
empirical basis for adjusting the severity based on functional 
disability, a substantial body of evidence (see Davis64 and 
Sheehan and Herman65 for recent reviews) suggests that BED 
is associated with psychiatric and medical comorbidities, 
functional disability, and impaired QoL.6,7,42,50,62,66–76
Psychiatric comorbidities and psychopathologies
Individuals with BED report higher rates of major depressive 
disorder, posttraumatic stress disorder, generalized anxiety 
disorder, obsessive–compulsive disorder, panic attacks, 
impulse control disorders, and substance abuse than indi-
viduals without BED.6,7,42,50,62,66–68 For example, the lifetime 
prevalence for any mood disorder and anxiety disorder among 
individuals with BED has been estimated to range from 46% 
to 54% and from 37% to 65%, respectively.6,7,42
The relationship between BED and psychiatric comor-
bidities may be complex and influenced by factors that 
include comorbid disease severity and race.44,77–81 Among 
individuals with BED, the severity of depression or anxiety 
symptoms can influence the likelihood of binge eating.77 
Similarly, emotional eating (ie, eating in response to nega-
tive emotions and anxiety) correlates with binge eating and 
most eating psychopathology measures in obese individuals 
with BED.78,79 Regarding race and ethnicity, individuals with 
BED who are Black or Hispanic have been found to be more 
than twice as likely as individuals with BED who are White 
to have a comorbid mood and anxiety disorder.80 Elevated 
psychiatric comorbidities in BED can occur independently 
of obesity and weight status, with studies reporting that 
individuals with BED who are obese and individuals with 
BED who are not obese have similar levels of depressive 
symptoms.44,81
In addition to psychiatric comorbidities, certain personal-
ity profiles and psychopathologies in individuals with BED 
are associated with binge eating behaviors.50,82 In a study of 
obese females with BED, binge eating severity was correlated 
with paranoid ideas, psychoticism, and interpersonal 
sensitivity.50 Furthermore, individuals with BED exhibit 
interpersonal problems, which are negatively correlated with 
age at first binge, and less flexible interpersonal styles, which 
increase the likelihood of meeting BED diagnostic criteria 
at a young age.82 
Taken together, this is a substantial evidence base indi-
cating that BED is associated with increased psychiatric 
comorbidity and psychopathology and distinctive personality 
profiles.44,50,77–82 It is important for clinicians to be aware of 
these comorbid conditions, because they may be the manifest 
reasons that individuals with BED seek treatment, particularly 
if they are not aware that BED is an actual disorder. Further-
more, the personality profiles, presence of specific comorbidi-
ties, and their severity may influence treatment strategies.
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Nonpsychiatric comorbidities and medical profiles
BED is associated with nonpsychiatric medical comorbidities 
that include sleep disturbances, type 2 diabetes, metabolic 
syndrome, and gastrointestinal distress.69–73 A large percent-
age of individuals with BED (40%) meet the criteria for 
metabolic syndrome.69,70 Consistent with this finding, in a 
5-year longitudinal study, individuals with BED who were 
obese were found to be at increased risk for developing com-
ponents of metabolic syndrome compared with individuals 
without BED who were BMI-matched to those with BED.74 
In a study of weight loss surgery candidates, ~8% of indi-
viduals met diagnostic criteria for both type 2 diabetes and 
BED, with black race and male sex being strong indicators 
of the co-occurrence of these disorders.71 
Functional disability and QoL
Data on QoL and functional disability in individuals with 
BED are relatively limited, but publications to date do sup-
port the concept that BED is associated with impaired QoL 
and with increased functional disability.7,73,75,76,83 Based on the 
Medical Outcomes 36-item Study Short-Form Health Survey, 
all domains of health-related QoL are impaired in individuals 
with BED relative to the normative US population and on the 
emotional role limitation, mental health, and social function-
ing domains relative to obese individuals without BED.76 
Furthermore, in a study of females conducted at primary 
care and gynecologic clinics throughout the US, BED was 
associated with worse health-related QoL on all domains of 
the Medical Outcomes 20-item Study Short-Form Health 
Survey compared with females without psychiatric disor-
ders.73 In regard to functional disability, BED is associated 
with impaired role attainment relative to individuals without 
BED as measured by females with BED (but not males) being 
less likely to marry and males with BED (but not females) 
being less likely to be employed.75 On the Sheehan Disability 
Scale, ~50% of individuals with BED reported some level of 
role impairment.7 In a randomized, placebo-controlled study 
of topiramate,83 mean Sheehan Disability Scale total scores 
at baseline (~12 points) were indicative of mild-to-moderate 
functional impairment.84 
Limitations of the DSM-5 diagnostic 
criteria for BED
The DSM-5 diagnostic criteria for BED are intended to 
identify a population of individuals whose psychopathologic 
and behavioral profiles are distinct from other eating disor-
ders and obesity. However, there are several limitations of 
the current criteria and outstanding issues that remain to be 
addressed. The strongest evidence supporting the DSM-5 
diagnostic criteria is available for the loss of control,20–24 
marked distress,2,11,23,29,31–34 and the frequency/duration 
criteria.29,37–40 Although the presence of loss of control over 
eating in BED is empirically supported in the published 
literature,20–24 the role of subjective binge eating episodes in 
BED has not been extensively studied, and what constitutes 
consuming an amount of food that is “definitely larger than 
what most people would eat under similar circumstances…”1 
during an objective binge eating episode is not well defined 
and is based on clinical judgment.
An index of BED severity is included in the DSM-5, which 
establishes a minimum level of severity based on the number 
of binge eating episodes per week (mild, 1–3; moderate, 4–7; 
severe, 8–13; and extreme, 14) and allows for increases in 
severity based on the presence of comorbidities and functional 
disabilities.1 This represents an expansion of the criteria com-
pared with the DSM-IV-TR, in which severity criteria were 
not included.35 Although there is some evidence supporting 
the new severity criterion based on the number of weekly 
binge eating episodes,47,48 the degree to which comorbidities, 
other symptoms, or functional disability influence severity is 
not clear. Furthermore, the impact of the method that is used 
to assess symptom severity needs to be clarified because 
symptom level could vary between patient self-report versus 
physician-administered clinical interview. In addition, a sys-
tematic review reported that some self-reported binge eating 
measures exhibit better psychometric properties than others 
but that further study is required in terms of the validity and 
reliability of most binge eating measures.85 
Overvaluation of shape/weight is not addressed in the 
DSM-5, despite the fact that it has been recognized by 
researchers as an important feature of BED.24,57 Overvalua-
tion of shape/weight is known to have prognostic value for 
BED32,57 and is included as part of the diagnostic criteria for 
BN and AN.1 Although there is empirical evidence for not 
including overvaluation of shape/weight as a required crite-
rion for BED,10 its total exclusion from the DSM-5 criteria is 
not warranted based on its prognostic value and association 
with the severity of eating disorder pathologies in individuals 
with BED.10,15,30,32,41,57,59 Using the overvaluation of shape and 
weight to designate a distinct subtype of BED or as a modifier 
of BED severity should be taken into consideration. 
Although individuals meeting DSM-5 criteria for BED 
share commonalities (eg, more likely to be overweight, to 
be female, and to have elevated anxiety and/or depression), 
there are important individual differences among individu-
als with BED. Future research should examine the utility 
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of including distinct subtypes of BED in the diagnostic 
criteria. In support of this recommendation, a factor analysis 
from one study identified two BED subtypes (a pure dietary 
subtype and a negative affect BED subtype), with the latter 
exhibiting a higher frequency of binge eating episodes and 
sensitivity to punishment, as measured by the Sensitivity 
to Punishment and Sensitivity to Reward Questionnaire.86 
Another analysis identified four distinct BED classes (Class 
1: increased physical activity levels and lower BMI; Class 
2: high levels of binge eating, shape/weight concerns, com-
pensatory behaviors, and negative affect; Class 3: high levels 
of binge eating with low levels of exercise or compensation; 
and Class 4: high BMI, frequent overeating with fewer 
binge episodes, and no compensatory behavior).87 Of note, 
the potential existence of a BED subtype characterized by 
compensatory behavior complicates the current diagnostic 
guidelines and renders indistinct the differences between 
BED and other eating disorders. Lastly, although individuals 
with BED who are not obese have been reported to be similar 
to individuals with BED who are obese in many ways,44,81 
it has been reported that individuals with BED who are not 
obese may display more dietary and cognitive restraint than 
individuals with BED who are obese.81 Although not all stud-
ies have replicated this finding,44 the potentially increased 
restraint in individuals with BED who are not obese may 
blur the distinction between BED and nonpurging BN (ie, 
individuals with BN who compensate through dietary fasting 
or excessive exercising rather than purging).
Conclusion
The diagnostic entity of BED, which has been recognized in 
clinical settings and the research literature for 50 years,2 
is a heterogeneous and complex disorder. Individuals diagnosed 
with BED often exhibit a unique clinical profile consisting of 
psychiatric6,7,42,50,62,66–68 (eg, mood, obsessive–compulsive, and 
impulsive disorders) and nonpsychiatric medical69–73 (eg, sleep 
disturbance, gastrointestinal symptoms, metabolic syndrome, 
and type 2 diabetes) comorbidities, psychopathologies32,57,63 
(eg, overvaluation of shape and weight), and personality/
behavioral traits17–19,50,78,79,82,88 (eg, overconsumption of 
calories, emotional eating, and interpersonal problems). 
Because comorbid conditions may be one of the reasons 
individuals with BED seek treatment, physicians need to be 
aware of their presence. Although evidence indicates that BED 
is more prevalent than both AN and BN6,7 and is associated 
with worse QoL73,76 and increased functional disability,7,75,83 
BED continues to be underrecognized, underdiagnosed, and 
undertreated in clinical settings.7
When considering patients with putative BED, health care 
professionals should focus on the presence of clinical indica-
tors and risk factors to aid in diagnosis.89 These indicators can 
include obesity and clinically significant weight gain (5% 
of body weight) in the past year, psychiatric and medical 
comorbidities, and a family history of BED. There are also 
assessment tools that can be used by health care professionals 
when assessing the patients for potential BED. These include 
the validated seven-item binge eating disorder screener 
(BEDS-7),90 the validated Eating Disorder Assessment for 
the DSM-5,91 and the Eating disorder Screen for Primary 
Care (ESP).92 The ESP and Eating Disorder Assessment for 
the DSM-5 are limited in that they do not focus specifically 
on BED, as does the BEDS-7. Furthermore, the BEDS-7 and 
ESP are screeners that are not intended to be used as diagnostic 
tools; individuals who screen positive on the BEDS-7 or ESP 
should be referred to a specialist for a formal diagnosis. 
With the release of the DSM-5 diagnostic criteria for 
BED and its inclusion in the main text of the DSM-5 as a 
distinct eating disorder, it is expected that BED will become 
increasingly recognized, diagnosed, and treated by both 
psychiatrists and primary care physicians. Based on a review 
of the published literature in PubMed, empirical evidence 
supports the legitimacy of the duration/frequency criterion 
for BED and the primary importance of loss of control over 
eating and marked distress in BED. However, there is a lack 
of clarity regarding what constitutes a “large amount of food” 
with reference to binge eating and whether subjective binge 
eating should be considered in the BED diagnostic criteria. 
These findings should be considered in light of the fact 
that only a single database was used in the current review. 
In addition, although overvaluation of shape/weight is not 
a diagnostic criterion in the DSM-5, the published literature 
suggests that it is strongly related to eating pathology sever-
ity in individuals with BED and may identify an important 
subgroup of individuals with BED or serve as an index of 
severity. Future revisions of the DSM criteria for BED should 
consider whether to include the undue influence of body 
shape and weight on self-evaluation as a specifier indicating 
a BED subtype.
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